Kevin D. Freeman
Director at Galectin Therapeutics · 2 reported transactions in 1 company · latest trade Dec 23, 2025
Their record
Across their whole record, 1 purchase can be measured; 1 did better than the S&P 500 over the next 6 months.
Typical move +22.5%, S&P 500 +9.8% over the same days.
Their trades
Bought | Dec 23, 2025 | Dec 23, 2025 close $3.99 → Oct 29, 2026 close $3.52. S&P 500 +11.8% over the same days. | ||
Bought | Jul 17, 2025 | Jul 17, 2025 close $2.89 → Oct 29, 2026 close $3.52. S&P 500 +22.5% over the same days. |
BoughtGalectin Therapeutics
$19.5K
Dec 23, 2025 close $3.99 → Oct 29, 2026 close $3.52. S&P 500 +11.8% over the same days.
BoughtGalectin Therapeutics
$14.5K
Jul 17, 2025 close $2.89 → Oct 29, 2026 close $3.52. S&P 500 +22.5% over the same days.